International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index; 5 of the 68 sources its claims cite were checked for support.
Abstract
In the accompanying comment letter (1), Weinert summarizes published data from the Brazilian Gestational Diabetes Study (2) and comments on applying International Association of Diabetes and Pregnancy Study Groups (IADPSG) Consensus Panel recommendations (3) for the diagnosis of gestational diabetes mellitus (GDM) to that cohort. The Brazilian study provided evidence that adverse perinatal outcomes are associated with levels of maternal glycemia below those diagnostic of GDM by American Diabetes Association or World Health Organization criteria. However, the results were potentially confounded by the treatment of GDM. It did find that women with GDM were at increased risk for some …
Overview
CoChat Summary
## TL;DR
This IADPSG consensus report recommends new gestational diabetes mellitus (GDM) diagnostic thresholds based on HAPO study data, using a 75-g OGTT and outcome-linked glucose cutoffs. It also recommends early detection of overt diabetes in pregnancy and notes that these recommendations will increase the frequency of diagnosed hyperglycemic disorders in pregnancy.
## Key findings
- In the HAPO study, a 75-g OGTT was performed in a heterogeneous, multinational, multicultural, ethnically diverse cohort of approximately 25,000 women in the third trimester; medical caregivers were blinded unless predefined glucose criteria were exceeded.
- The report states that the HAPO data showed continuous, graded associations between maternal glucose and primary outcomes, with no obvious thresholds; associations were also observed for secondary outcomes and did not differ among centers.
- The recommended diagnostic thresholds correspond to glucose levels where odds for birth weight >90th percentile, cord C-peptide >90th percentile, and percent body fat >90th percentile reached 1.75 times the estimated odds at mean glucose values; by these criteria, FPG alone identified 8.3% of the HAPO cohort, FPG plus 1-hour glucose identified an additional 5.7%, and 2-hour glucose another 2.1%, for a total GDM incidence of 17.8%.
- Among the HAPO cohort, 11.1% had only one elevated result, 3.9% had two elevated results, 1.1% had all three elevated, and 1.7% were unblinded because FPG or 2-hour glucose exceeded 5.8 mmol/l (105 mg/dl) or 11.1 mmol/l (200 mg/dl).
## Methods
- Consensus report based on review of the HAPO study, additional unpublished HAPO findings, and other published studies discussed at a June 2008 IADPSG workshop/meeting in Pasadena, followed by consensus panel deliberation.
- HAPO design described as observational: a 75-g OGTT in a large multinational cohort, with blinded caregivers except for preset safety thresholds.
- Thresholds were derived from fully adjusted logistic regression models relating continuous maternal glucose measures (FPG, 1-hour, 2-hour) to outcomes; the panel selected an odds ratio threshold of 1.75 relative to mean glucose values.
## Limitations
- The paper states that recommendations for detecting overt diabetes during pregnancy are based on the opinions of the IADPSG Consensus Panel because prospective studies or appropriately designed clinical trials were not available.
- It states that it was not determined whether universal early testing for overt diabetes is clinically valuable or cost-effective.
- Evident from the text: the HAPO study was observational, not a clinical trial, so the diagnostic thresholds are inferred from associations rather than randomized intervention effects.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
4 Valid · 0 Not valid · 36 Not checked · 22 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Similar associations were also observed for secondary outcomes (25,26).”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > THE HAPO STUDY
What the sources say
- Not checked yetcites [25] HAPO Study Cooperative Research Group Metzger BE Lowe LP Dyer AR Trimble ER Chaovarindr U Coustan DR Hadden DR McCance DR Hod M McIntyre HD Oats JJ Persson B Rogers MS Sacks DA: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991– 2002 18463375 source
- Supportedcites [26] HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009; 58: 453– 459 19011170 PMC2628620 source
The Abstract of our copy states that the predefined primary outcomes (size at birth, cesarean delivery, neonatal hypoglycemia, fetal hyperinsulinemia) were reported elsewhere, and that this report's goals were to examine maternal glycemia against additional/newborn anthropometric outcomes (sum of skin folds, individual skin folds, percent body fat) plus cord C-peptide. The Results report strong, graded, continuous associations for these outcomes (e.g., ORs 1.33–1.47 for percent body fat >90th percentile and 1.28–1.56 for individual skin folds), and the Discussion explicitly says 'This pattern is similar to that reported for maternal glucose and birth weight >90th percentile.' That covers the claim's substance — similar associations for the secondary/additional outcomes — even though the paper does not use the label 'secondary outcomes'. (LLM, conf=0.85)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Associations of LGA and excess adiposity with fetal hyperinsulinemia are strong and independent of confounders (26,37,38).”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > TRANSLATION OF HAPO STUDY RESULTS FOR DIAGNOSIS OF GDM
What the sources say
- Supportedcites [26] HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009; 58: 453– 459 19011170 PMC2628620 source
In the Results (Table 5), higher cord C-peptide, the paper’s measure of fetal insulin, is strongly associated with birth weight above the 90th percentile and adiposity measures. The Discussion states that the relationships persisted after adjustment for potential confounders. The paper does not claim that every possible confounder was excluded. (LLM, conf=0.92)
- Not checked yetcites [37] Metzger BE Silverman BL Freinkel N Dooley SL Ogata ES Green OC: Amniotic fluid insulin concentration as a predictor of obesity. Arch Dis Child 1990; 65: 1050– 1052 2241225 PMC1590256 source
- Not checked yetcites [38] Weiss PA Haeusler M Tamussino K Haas J: Can glucose tolerance test predict fetal hyperinsulinism? BJOG 2000; 107: 1480– 1485 11192103 source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Although not directly comparable, it was concluded that results of the two randomized controlled trials (47,48) and HAPO (25,26) are highly complementary.”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > TRANSLATION OF HAPO STUDY RESULTS FOR DIAGNOSIS OF GDM > Other considerations
What the sources say
- Supportedcites [47] Crowther CA Hiller JE Moss JR McPhee AJ Jeffries WS Robinson JS: Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 352: 2477– 2486 15951574 source
The paper identifies itself as a randomized clinical trial and reports its treatment results (secondary outcomes; page unavailable). In the citing sentence, this citation identifies one of the two trials whose results are being discussed; it does not attribute the cross-study judgment of complementarity to this trial paper. (LLM, conf=0.88)
- Not checked yetcites [48] Landon MB Spong CY Thom E Carpenter MW Ramin SM Casey B Wapner RJ Varner MW Rouse DJ Thorp JM Jr Sciscione A Catalano P Harper M Saade G Lain KY Sorokin Y Peaceman AM Tolosa JE Anderson GB: Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009: 361; 1339– 1348. PMC2804874 19797280
- Not checked yetcites [25] HAPO Study Cooperative Research Group Metzger BE Lowe LP Dyer AR Trimble ER Chaovarindr U Coustan DR Hadden DR McCance DR Hod M McIntyre HD Oats JJ Persson B Rogers MS Sacks DA: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991– 2002 18463375 source
- Could not verifycites [26] HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009; 58: 453– 459 19011170 PMC2628620 sourceExperimental — accuracy not yet measured
The Abstract reports HAPO findings on maternal glucose and pregnancy outcomes, but does not compare them with randomized trials. Searches for randomized trials and for the claimed complementarity found no passage in our copy making that comparison. No page numbers were available. (LLM, conf=0.70)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
In the paper
“Importantly, there were continuous graded relationships between higher maternal glucose and increasing frequency of the primary outcomes, independent of other risk factors (25).”
- Also stated in: § Future considerations · boosted
“The HAPO study was a basic epidemiological investigation that for the first time conclusively identified strong continuous associations of maternal glucose levels below those diagnostic of diabetes with several perinatal outcomes.”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > THE HAPO STUDY
What the sources say
- Not checked yetcites [25] HAPO Study Cooperative Research Group Metzger BE Lowe LP Dyer AR Trimble ER Chaovarindr U Coustan DR Hadden DR McCance DR Hod M McIntyre HD Oats JJ Persson B Rogers MS Sacks DA: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991– 2002 18463375 source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Future considerations · boosted
None of the sources cited for this claim have been checked yet.
In the paper
“HAPO data show strong linear associations of risks for >90th percentiles of birth weight, cord C-peptide, and percent body fat with each of three measures of maternal glucose (FPG, 1-h, and 2-h post–75-g load).”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > TRANSLATION OF HAPO STUDY RESULTS FOR DIAGNOSIS OF GDM
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
40 more claims
Create a free account to see all 62 claims and to verify the 63 references still open.
- It may state two separate claims as one. 10
- Probably not a substantial claim. 8
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“GDM was identified when fasting blood glucose (FBG) ≥ 5.1 mmol/L during the first trimester or any plasma glucose after a 75 g OGTT performed as: FBG ≥ 5.1 mmol/L, 1 h after glucose load ≥ 10.0 mmol/L or 2 h after glucose load ≥ 8.5 mmol/L using the criteria of International Association of Diabetes and Pregnancy Study Groups (IADPSG) [28].”
From Associations of maternal pre-pregnancy BMI and gestational weight gain with the risks of adverse pregnancy outcomes in Chinese women with gestational diabetes mellitus (2023) · cites this paper as [28]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“to adopt diagnostic glucose thresholds corresponding to a HAPO OR of 1.75 (fasting plasma glucose [FPG] 5.1–6.9 mmol/L, one‐hour plasma glucose [1hPG] ≥ 10.0 mmol/L, and/or two‐hour plasma glucose [2hPG] 8.5–11.0 mmol/L). 14”
From Australasian Diabetes in Pregnancy Society ( ADIPS ) 2025 consensus recommendations for the screening, diagnosis and classification of gestational diabetes (2025) · cites this paper as [14]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The IADPSG diagnostic thresholds are the first criteria based on risks of adverse perinatal outcomes, rather than risk of subsequent development of maternal diabetes1 or by applying thresholds that define impaired glucose tolerance outside of pregnancy.5,6”
From Gestational Diabetes Mellitus (2019) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“following the diagnostic criteria proposed by the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) (18)”
From Diabetes gestacional y riesgo de apnea obstructiva del sueño en el tercer trimestre (2025) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“Based on the HAPO Study and other studies, new criteria for the diagnosis of gestational diabetes were proposed by the International Association of Diabetes and Pregnancy Study Groups (IADPSG) 2 and adopted by the World Health Organization and others.3,4”
From Association of Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood Adiposity (2018) · cites this paper as [2]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Prevalence of Overweight and Obesity in the United States, 1999-2004
Ogden, C. L., Carroll, M. D., Curtin, L. R., McDowell, M. A., Tabak, C. J., & Flegal, K. M. (2006) · JAMA · doi:10.1001/jama.295.13.1549 · Cited by 8,720
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Boney, C. M., Verma, A., Tucker, R., & Vohr, B. R. (2005) · Pediatrics · doi:10.1542/peds.2004-1808 · Cited by 2,303 · cited 2×
“Long-term risks associated with fetal macrosomia in infants of women with GDM (independent of confounders) include childhood overweight (43,44) and metabolic factors that may increase risk of cardiovascular disease (CVD) (45).”
BackgroundA Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122
Metzger, B. E., Buchanan, T. A., Coustan, D. R., de Leiva, A., Dunger, D. B., Hadden, D. R., Hod, M., Kitzmiller, J. L., Kjos, S. L., Oats, J. N., et al. (2007) · Diabetes Care · doi:10.2337/dc07-s225 · Cited by 1,908
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s062 · Cited by 1,817
(1964) · PubMed · Cited by 1,230
Research works printed but not linked: 2
- Canadian Task Force on the Periodic Health Examination. The Canadian guide to clinical preventive health care. Health Canada 1994; 15– 23
- National Collaborating Centre for Women's and Children's Health. Diabetes in Pregnancy: Management of Diabetes and Its Complications from Preconception to the Postnatal Period. London, U.K., RCOG Press, 2008 21370515
Cited by
Items 1,001–1,100 of 1,132
Shahbazian, H., Nouhjah, S., Shahbazian, N., Jahanfar, S., Latifi, S. M., Aleali, A., Shahbazian, N., & Saadati, N. (2016) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2016.06.019 · Cited by 37
Kyozuka, H., Yasuda, S., Murata, T., Fukuda, T., Yamaguchi, A., Kanno, A., Sato, A., Ogata, Y., Hosoya, M., Yasumura, S., et al. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13569 · Cited by 37
Early pregnancy hemoglobin A1C and pregnancy outcomes: a population-based study
Chen, L., Pocobelli, G., Yu, O., Shortreed, S. M., Osmundson, S. S., Fuller, S., Wartko, P. D., Mcculloch, D., Warwick, S., Newton, K. M., et al. (2019) · American Journal of Perinatology · doi:10.1055/s-0038-1675619 · Cited by 36
Pregnancy outcomes according to the definition of gestational diabetes
Koivunen, S., Viljakainen, M., Männistö, T., Gissler, M., Pouta, A., Kaaja, R., Eriksson, J., Laivuori, H., Kajantie, E., & Vääräsmäki, M. (2020) · PLOS ONE · doi:10.1371/journal.pone.0229496 · Cited by 36
Finding Genetic Risk Factors of Gestational Diabetes
Kwak, S. H., Jang, H. C., & Park, K. S. (2012) · Genomics & Informatics · doi:10.5808/gi.2012.10.4.239 · Cited by 36
Simmons, D., Immanuel, J., Hague, W. M., Teede, H., Nolan, C. J., Peek, M. J., Flack, J. R., McLean, M., Wong, V., Hibbert, E. J., et al. (2024) · Diabetes Care · doi:10.2337/dc23-1667 · Cited by 36
Haque, M. M., Tannous, W. K., Herman, W. H., Immanuel, J., Hague, W. M., Teede, H., Enticott, J., Cheung, N. W., Hibbert, E., Nolan, C. J., et al. (2024) · eClinicalMedicine · doi:10.1016/j.eclinm.2024.102610 · Cited by 35
“8,11 The options for assessment include an oral glucose tolerance test (OGTT), hemoglobin A1c (HbA1c), fasting or random plasma glucose testing which often identi fi es women with milder hyperglycemia than DIP.”
BackgroundCarbohydrates, Glycemic Index, and Pregnancy Outcomes in Gestational Diabetes
Louie, J. C. Y., Brand-Miller, J. C., & Moses, R. G. (2013) · Current Diabetes Reports · doi:10.1007/s11892-012-0332-1 · Cited by 35
Anxiety, Prenatal Attachment, and Depressive Symptoms in Women with Diabetes in Pregnancy
Napoli, A., Lamis, D. A., Berardelli, I., Canzonetta, V., Sarubbi, S., Rogante, E., Napoli, P.-L., Serafini, G., Erbuto, D., Tambelli, R., et al. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17020425 · Cited by 34
Kereliuk, S. M., & Dolinsky, V. W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084467 · Cited by 34
Ramezani Tehrani, F., Naz, M. S. G., Yarandi, R. B., & Behboudi-Gandevani, S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040666 · Cited by 34
Fadl, H., Saeedi, M., Montgomery, S., Magnuson, A., Schwarcz, E., Berntorp, K., Sengpiel, V., Storck-Lindholm, E., Strevens, H., Wikström, A.-K., et al. (2019) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-019-2547-5 · Cited by 34
“The IADPSG recommend universal screening [18], however, in Sweden there has been a diverse approach to screening as shown in Table 1.”
MethodBenhalima, K., Van Crombrugge, P., Moyson, C., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., Maes, T., Dufraimont, E., De Block, C., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8030383 · Cited by 33
Physical activity in pregnancy prevents gestational diabetes: A meta-analysis
Doi, S. A. R., Furuya-Kanamori, L., Toft, E., Musa, O. A. H., Mohamed, A. M., Clark, J., & Thalib, L. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108371 · Cited by 33
“[26] Metzger BE, Gabbe SG, Persson B et al.”
BackgroundMethodPregnancy outcomes of women with hypoglycemia in the oral glucose tolerance test
Bayraktar, B., Balıkoğlu, M., & Kanmaz, A. G. (2020) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2020.101703 · Cited by 33
Caissutti, C., Khalifeh, A., Saccone, G., & Berghella, V. (2018) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.13254 · Cited by 32
Gestational Diabetes and Future Risk of Diabetes
Sivaraman (2013) · Journal of Clinical Medicine Research · doi:10.4021/jocmr1201w · Cited by 32
“5 mmol/L following a 75 gram OGTT [22].”
Gestational Diabetes: An Update 60 Years After O’Sullivan and Mahan
McIntyre, H. D., Kampmann, U., Dalsgaard Clausen, T., Laurie, J., & Ma, R. C. W. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae709 · Cited by 32
for the Target Study Group, Crowther, C. A., Alsweiler, J. M., Hughes, R., & Brown, J. (2018) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-018-2060-2 · Cited by 31
Adverse maternal and neonatal outcomes in pregnant women with abnormal glucose metabolism
Li, M.-F., Ma, L., Yu, T.-P., Zhu, Y., Chen, M.-Y., Liu, Y., & Li, L.-X. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108085 · Cited by 31
Tamayo, T., Tamayo, M., Rathmann, W., & Potthoff, P. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.03.001 · Cited by 31
Diagnosis of gestational diabetes mellitus will be flawed until we can measure glucose
Bruns, D. E., Metzger, B. E., & Sacks, D. B. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvz027 · Cited by 30
The impact of ethnicity on glucose homeostasis after gestational diabetes mellitus
Ignell, C., Shaat, N., Ekelund, M., & Berntorp, K. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0484-8 · Cited by 30
Missed follow-up opportunities using a two-step screening approach for gestational diabetes
Sievenpiper, J. L., McDonald, S. D., Grey, V., & Don-Wauchope, A. C. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.01.030 · Cited by 30
“This position was recently endorsed by the IADPSG [2] and subsequently the American Diabetes Association [5] in the recommendation to move to a 1-step GDM screening policy.”
BackgroundInfluentialVarela, P., Spyropoulou, A. C., Kalogerakis, Z., Vousoura, E., Moraitou, M., & Zervas, I. M. (2017) · Primary Health Care Research & Development · doi:10.1017/s1463423617000317 · Cited by 30
“Gestational diabetes mellitus (GDM) is defined as any degree of glucose or carbohydrate intolerance with onset or first recognition during pregnancy (ACOGCommittee on Practice Bulletins-Obstetrics, 2004; International Association of Diabetes and Pregnancy Study Groups Consensus Panel et al., 2010).”
BackgroundScreening for gestational diabetes in Tuscany, Italy. A population study
Di Cianni, G., Gualdani, E., Berni, C., Meucci, A., Roti, L., Lencioni, C., Lacaria, E., Seghieri, G., & Francesconi, P. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.08.003 · Cited by 30
Tagoma, A., Haller‐Kikkatalo, K., Oras, A., Roos, K., Kirss, A., & Uibo, R. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13828 · Cited by 30
Pathirana, M. M., Ali, A., Lassi, Z. S., Arstall, M. A., Roberts, C. T., & Andraweera, P. H. (2022) · Journal of Human Lactation · doi:10.1177/08903344211034779 · Cited by 29
“GDM is currently defined based on the International Association of Diabetes in Pregnancy Study Group (IADPSG) guidelines (Metzger et al., 2010).”
MethodDu, Y., Fang, Z., Jiao, J., Xi, G., Zhu, C., Ren, Y., Guo, Y., & Wang, Y. (2021) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.22037 · Cited by 29
Song, X., Chen, L., Zhang, S., Liu, Y., Wei, J., Wang, T., & Qin, J. (2022) · Nutrients · doi:10.3390/nu14163347 · Cited by 28
Kawasaki, M., Arata, N., Sakamoto, N., Osamura, A., Sato, S., Ogawa, Y., Yasuhi, I., Waguri, M., & Hiramatsu, Y. (2020) · Endocrine Journal · doi:10.1507/endocrj.ej19-0367 · Cited by 27
Popova, P., Vasilyeva, L., Tkachuck, A., Puzanov, M., Golovkin, A., Bolotko, Y., Pustozerov, E., Vasilyeva, E., Li, O., Zazerskaya, I., et al. (2018) · International Journal of Endocrinology · doi:10.1155/2018/6481658 · Cited by 27
“GDM was diagnosed according to the Russian National Consensus [16] and the recommendations of the International Association of Diabetes and Pregnancy Study Groups (IADPSG) based on the results of 2-hour oral glucose tolerance test (OGTT) performed at 24th–28th week of gestation [17].”
MethodPerformance of early risk assessment tools to predict the later development of gestational diabetes
Kotzaeridi, G., Blätter, J., Eppel, D., Rosicky, I., Mittlböck, M., Yerlikaya‐Schatten, G., Schatten, C., Husslein, P., Eppel, W., Huhn, E. A., et al. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13630 · Cited by 27
Jamieson, E. L., Spry, E. P., Kirke, A. B., Atkinson, D. N., & Marley, J. V. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16224488 · Cited by 27
“HAPO data was selected due the robust study design, including strict pre-analytical OGTT protocol, which was standardised across multiple international sites [2,3].”
BackgroundMethodWeiss, C., Oppelt, P., & Mayer, R. B. (2019) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-018-4964-5 · Cited by 27
He, Y., Liu, C., Han, Y., Huang, Y., Zhou, J., & Xie, Q. (2021) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-021-04155-z · Cited by 26
A meta-analysis of adverse offspring health outcomes in patients with gestational diabetes mellitus
Guan, J., Qiu, J., Li, L., Fu, M., Zhang, M., Wu, Y., Xu, Y., Ding, H., & Gao, Q. (2025) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.16341 · Cited by 27
“18 The commonly used screening methods for GDM mainly include the one-step method, the two-step method and the ‘ other ’ method.”
Sweeting, A., Hare, M. J., de Jersey, S. J., Shub, A. L., Zinga, J., Foged, C., Hall, R. M., Wong, T., & Simmons, D. (2025) · Medical Journal of Australia · doi:10.5694/mja2.52696 · Cited by 26
Dainelli, L., Prieto Patron, A., Silva-Zolezzi, I., Sosa Rubi, S. G., Espino y Sosa, S., Reyes Muñoz, E., Lopez-Ridaura, R., & Detzel, P. (2018) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s160658 · Cited by 26
Wood, A. J., Boyle, J. A., Barr, E. L. M., Barzi, F., Hare, M. J. L., Titmuss, A., Longmore, D. K., Death, E., Kelaart, J., Kirkwood, M., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109092 · Cited by 24
Iwama, N., Sugiyama, T., Metoki, H., Kusaka, H., Yaegashi, N., Sagawa, N., Hiramatsu, Y., Toyoda, N., & The JAGS Group (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13044 · Cited by 24
Brankica, K., Valentina, V. N., Slagjana, S. K., & Sasha, J. M. (2016) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000126 · Cited by 23
Fetal sex and maternal insulin resistance during mid-pregnancy: a retrospective cohort study
Yamashita, H., Yasuhi, I., Koga, M., Sugimi, S., Umezaki, Y., Fukuoka, M., Suga, S., Fukuda, M., & Kusuda, N. (2020) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-020-03242-x · Cited by 23
Wei, Y.-M., Liu, X.-Y., Shou, C., Liu, X.-H., Meng, W.-Y., Wang, Z.-L., Wang, Y.-F., Wang, Y.-Q., Cai, Z.-Y., Shang, L.-X., et al. (2019) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000158 · Cited by 22
Towards a global consensus on GDM diagnosis: Light at the end of the tunnel?
Kapur, A., McIntyre, H. D., Divakar, H., Di Renzo, G. C., Kihara, A. B., McAuliffe, F., Hanson, M., Ma, R. C., Hod, M., & FIGO Working Group on Hyperglycemia in Pregnancy (2020) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13149 · Cited by 22
Sudasinghe, B. H., Ginige, P. S., & Wijeyaratne, C. N. (2016) · Ceylon Medical Journal · doi:10.4038/cmj.v61i4.8379 · Cited by 22
One-Step Approach to Identifying Gestational Diabetes Mellitus: Association With Perinatal Outcomes
Pocobelli, G., Yu, O., Fuller, S., Fraser, J. R., Wartko, P. D., Chen, L., Newton, K. M., Dimer, J., McCulloch, D. K., Warwick, S., et al. (2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002780 · Cited by 22
Liu, J., Liu, E., Leng, J., Pan, L., Zhang, C., Li, W., Li, J., Huo, X., Chan, J. C. N., Yu, Z., et al. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.08.023 · Cited by 21
Li, M.-F., Ke, J.-F., Ma, L., Wang, J.-W., Zhang, Z.-H., Li, J.-B., & Li, L.-X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.754406 · Cited by 20
Sweeting, A., MacMillan, F., Simmons, D., & attendees, F. T. T. S. (2024) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.13823 · Cited by 21
Selective screening for GDM in Italy: Application and effectiveness of National Guidelines
Lacaria, E., Lencioni, C., Russo, L., Romano, M., Lemmi, P., Battini, L., Del Prato, S., Bertolotto, A., & Di Cianni, G. (2015) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2014.969701 · Cited by 21
“In 2010, the International Association of Diabetes and Pregnancy Study Group (IADPSG) panel reconsidering the results of the HAPO study [1], proposed a new set of diagnostic criteria [2] along with the recommendation that all pregnant women should be screened for GDM, irrespective of”
BackgroundMethodImpact of different glycaemic treatment targets on pregnancy outcomes in gestational diabetes
Abell, S. K., Boyle, J. A., Earnest, A., England, P., Nankervis, A., Ranasinha, S., Soldatos, G., Wallace, E. M., Zoungas, S., & J Teede, H. (2019) · Diabetic Medicine · doi:10.1111/dme.13799 · Cited by 20
Prognosis Associated with Sub-Types of Hyperglycaemia in Pregnancy
Cosson, E., Bentounes, S. A., Nachtergaele, C., Berkane, N., Pinto, S., Sal, M., Bihan, H., Tatulashvili, S., Portal, J.-J., Carbillon, L., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10173904 · Cited by 20
Shang, M., Lin, L., Ma, L., & Yin, L. (2014) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443615.2013.832177 · Cited by 19
“Gestational diabetes mellitus (GDM) is one of the most common medical complications during pregnancy and its prevalence is increasing around the world, probably because of increasing rates of overweight and obesity (Lawrence et al. 2009; Kim et al. 2010).”
BackgroundDaly, N., Flynn, I., Carroll, C., Stapleton, M., O'Kelly, R., & Turner, M. J. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2016.254466 · Cited by 19
Pharmacotherapy for gestational diabetes
Patti, A. M., Giglio, R. V., Pafili, K., Rizzo, M., & Papanas, N. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1509955 · Cited by 19
Nwali, S. A., Onoh, R. C., Dimejesi, I. B., Obi, V. O., Jombo, S. E., & Edenya, O. O. (2021) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-021-04168-8 · Cited by 18
“Previous GDM[5, 27], and previous macrosomia[27] did not predict the development of hyperglycemia in some other studies.”
BackgroundMethodResultBracco, P. A., Reichelt, A. J., Alves, L. F., Vidor, P. R., Oppermann, M. L. R., Duncan, B. B., & Schmidt, M. I. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01606-x · Cited by 18
From Mother to Child: Epigenetic Signatures of Hyperglycemia and Obesity during Pregnancy
Franzago, M., Borrelli, P., Di Nicola, M., Cavallo, P., D’Adamo, E., Di Tizio, L., Gazzolo, D., Stuppia, L., & Vitacolonna, E. (2024) · Nutrients · doi:10.3390/nu16203502 · Cited by 18
Wang, H.-Y., She, G.-T., Sun, L.-Z., Lu, H., Wang, Y.-P., Miao, J., Liu, K.-Z., Sun, C.-F., & Ju, H.-H. (2019) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000480 · Cited by 18
Lackovic, M., Milicic, B., Mihajlovic, S., Filimonovic, D., Jurisic, A., Filipovic, I., Rovcanin, M., Prodanovic, M., & Nikolic, D. (2021) · Medicina · doi:10.3390/medicina57080741 · Cited by 18
Aubry, E. M., Raio, L., & Oelhafen, S. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108830 · Cited by 17
Gorban de Lapertosa, S., Sucani, S., Salzberg, S., Alvariñas, J., Faingold, C., Jawerbaum, A., Rovira, G., & on behalf of the DPSG-SAD Group (2021) · Health Care for Women International · doi:10.1080/07399332.2020.1800012 · Cited by 17
“According to this criterion, the prevalence of GDM in the HAPO study was 17.8% (International Association IADPSG et al., 2010).”
BackgroundMethodInfluentialYew, T. W., Khoo, C. M., Thai, A. C., Kale, A. S., Yong, E. L., & Tai, E. S. (2014) · Endocrine Practice · doi:10.4158/ep14028.or · Cited by 17
Chatzakis, C., Sotiriadis, A., Fatouros, I. G., Jamurtas, A. Z., Deli, C. K., Papagianni, M., Dinas, K., & Mastorakos, G. (2022) · Diagnostics · doi:10.3390/diagnostics12071732 · Cited by 17
Boe, B., Barbour, L. A., Allshouse, A. A., & Heyborne, K. D. (2019) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2019.02.003 · Cited by 16
Comparison of healthcare utilization and outcomes by gestational diabetes diagnostic criteria
Lauring, J. R., Kunselman, A. R., Pauli, J. M., Repke, J. T., & Ural, S. H. (2018) · Journal of Perinatal Medicine · doi:10.1515/jpm-2017-0076 · Cited by 16
“In addition to the two-step screening and diagnostic method outlined above, there is a one-step method currently recommended by the International Association of Diabetes and Pregnancy Study Group [16].”
MethodMcIntyre, H. D., Oats, J. J. N., Kihara, A. B., Divakar, H., Kapur, A., Poon, L. C., & Hod, M. (2021) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13764 · Cited by 16
Wu, Q., Chen, Y., Ma, H., Zhou, T., Hu, Y., Liang, Z., & Chen, D. (2023) · Nutrition & Diabetes · doi:10.1038/s41387-023-00239-1 · Cited by 16
Tong, X., Yang, L., Jiang, C., Weng, Z., Zu, A., Hou, Y., Fang, Y., Yang, W., & Sun, S. (2023) · Reproductive Sciences · doi:10.1007/s43032-022-00904-3 · Cited by 16
Early pregnancy plasma fatty acid profiles of women later diagnosed with gestational diabetes
Tryggvadottir, E. A., Gunnarsdottir, I., Birgisdottir, B. E., Hrolfsdottir, L., Landberg, R., Hreidarsdottir, I. T., Hardardottir, H., & Halldorsson, T. I. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002326 · Cited by 16
Beyerlein, A., Koller, D., Ziegler, A.-G., Lack, N., & Maier, W. (2016) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-016-1060-3 · Cited by 16
“These guidelines were revised in 2011 following the WHO’s new diagnostic criteria [4].”
BackgroundMethodVergara Camargo, J. L. (2018) · Revista Médicas UIS · doi:10.18273/revmed.v31n2-2018002 · Cited by 15
The Korean Pregnancy Outcome Study (KPOS): Study Design and Participants
Choi, H., Kwak, D. W., Kim, M. H., Lee, S. Y., Chung, J. H., Han, Y. J., Park, H. J., Kim, M. Y., Cha, D. H., Koo, S., et al. (2021) · Journal of Epidemiology · doi:10.2188/jea.je20200055 · Cited by 15
Sampaio, Y., Porto, L. B., Lauand, T. C. G., Marcon, L. P., & Pedrosa, H. C. (2020) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000310 · Cited by 15
“This finding can be related to the fact that the new diagnosis criteria proposed by IADPSG (1) include many patients with milder glucose elevations.”
BackgroundInfluentialSarathi, V., Kolly, A., Chaithanya, H. B., & Dwarakanath, C. S. (2016) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.1515/rjdnmd-2016-0024 · Cited by 14
Non-pharmacological management of gestational diabetes: The role of myo-inositol
Guardo, F. D., Currò, J. M., Valenti, G., Rossetti, P., Di Gregorio, L. M., Conway, F., Chiofalo, B., Garzon, S., Bruni, S., & Rizzo, G. (2020) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2019-0111 · Cited by 14
Maternal gestational diabetes mellitus and offspring body mass index from 1 to 4 years
Shi, X., Wang, D., Lin, M., Su, W., Wang, L., Xiao, F., Huang, P., Liu, W., Zeng, J., Song, H., et al. (2020) · Endocrine Practice · doi:10.4158/ep-2019-0415 · Cited by 14
McMahon, L. E., O’Malley, E. G., Reynolds, C. M. E., & Turner, M. J. (2020) · BMC Health Services Research · doi:10.1186/s12913-020-05655-y · Cited by 14
Kim, M., Park, J., Kim, S. H., Kim, Y. M., Yee, C., Choi, S.-J., Oh, S.-Y., & Roh, C.-R. (2018) · Obstetrics & Gynecology Science · doi:10.5468/ogs.2018.61.3.309 · Cited by 13
Al Subhi, S. K., Al Kindi, R. M., Al Rawahi, A. H., Al Seyabi, I. S. A. S., & Al Mukhaini, A. A. M. (2021) · Oman Medical Journal · doi:10.5001/omj.2021.08 · Cited by 13
Meloncelli, N. J., Barnett, A. G., Cameron, C. M., McIntyre, D., Callaway, L. K., d'Emden, M. C., & de Jersey, S. J. (2023) · Medical Journal of Australia · doi:10.5694/mja2.52129 · Cited by 13
Luo, X., Gao, J., He, Z., Ji, J., Zhang, W., Wu, P., Guo, X., Cao, D., Xu, Z., Li, C., et al. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00940-8 · Cited by 12
Lucovnik, M., Steblovnik, L., Verdenik, I., Premru‐Srsen, T., Tomazic, M., & Tul, N. (2020) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13098 · Cited by 12
Honnorat, D., Disse, E., Millot, L., Mathiotte, E., Claret, M., Charrie, A., Drai, J., Garnier, L., Maurice, C., Durand, E., et al. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.03.003 · Cited by 12
Chaves, C., Cunha, F., Martinho, M., Garrido, S., Silva-Vieira, M., Estevinho, C., Melo, A., Figueiredo, O., Morgado, A., Almeida, M. C., et al. (2021) · Acta Diabetologica · doi:10.1007/s00592-020-01665-8 · Cited by 12
Wali, A. S., Rafique, R., Iftikhar, S., Ambreen, R., & Yakoob, M. Y. (2019) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.36.icon-suppl.1723 · Cited by 11
Hager, M., Ott, J., Castillo, D. M., Springer, S., Seemann, R., & Pils, S. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051523 · Cited by 11
“GDM, the main outcome parameter, was assessed using a 75 g 2-h oGTT, according to the International Association of Diabetes in Pregnancy Study Group’s (IADPSG) recommendations [19].”
MethodCorcoy, R., Lumbreras, B., Bartha, J. L., & Ricart, W. (2010) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2010.03.020 · Cited by 11
Tong, J.-N., Chen, Y.-X., Guan, X.-N., Liu, K., Yin, A.-Q., Zhang, H.-F., Wu, L.-L., & Niu, J.-M. (2022) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-022-04874-x · Cited by 11
Basha, A. S., Fram, K. M., Thekrallah, F. M., Irshaid, Z. A., Maswady, A. M., & Obeidat, Z. N. (2019) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-018-0635-0 · Cited by 11
Ehrlich, S. F., Hedderson, M. M., Xu, F., & Ferrara, A. (2019) · PLOS ONE · doi:10.1371/journal.pone.0216897 · Cited by 10
Mendez-Figueroa, H., Daley, J., Lopes, V. V., & Coustan, D. R. (2013) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2013.780594 · Cited by 10
Du, Y., Jiao, J., Ji, C., Li, M., Guo, Y., Wang, Y., Zhou, J., & Ren, Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-17129-8 · Cited by 10
Schenk, S., Ravussin, Y., Lacroix, A., Quansah, D. Y., & Puder, J. J. (2024) · Nutrients · doi:10.3390/nu16040560 · Cited by 10
Deng, Y., Tam, C. H. T., Yang, A., Shi, M., Yuen, L. Y., Ng, N. Y. H., Tsang, A. Y. T., Tsoi, K. Y., Ozaki, R., Li, A. M., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06468-6 · Cited by 10
“GDM was defined post hoc using International Association of Diabetes in Pregnancy Study Groups (IADPSG) criteria using the standard 75 g 2 h OGTT [18], with GDM if any one of the following criteria was met: fasting blood glucose values ≥5.1 mmol/l, 1 h glucose values ≥10.0 mmol/l or 2 h glucose…”
InfluentialWojtyla, C., Stanirowski, P., Gutaj, P., Ciebiera, M., & Wojtyla, A. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18020560 · Cited by 10
Chu, L. C. H., Sugiyama, T., & Ma, R. C. W. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13670 · Cited by 10
Milovanović, Z., Filimonović, D., Soldatović, I., & Karadžov Orlić, N. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11133916 · Cited by 10
Dias, T., Siraj, S. H. M., Aris, I. M., Li, L.-J., & Tan, K. H. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00682 · Cited by 9
Metadata
- Authors
- International Association of Diabetes and Pregnancy Study Groups Consensus Panel
- Corresponding author
- International Association of Diabetes and Pregnancy Study Groups Consensus Panel
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-03-01
- Volume
- 33
- Issue
- 3
- Pages
- 676-682
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2827530
- OpenAlex
- W2616235706
- Cited by
- 5,390
- References
- 56
- Citations by year
- 2026: 314 · 2025: 377 · 2024: 446 · 2023: 423 · 2022: 494 · 2021: 507 · 2020: 425 · 2019: 350 · 2018: 367 · 2017: 297 · 2016: 274 · 2015: 296 · 2014: 235 · 2013: 203 · 2012: 167
- FWCI
- 250.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- American Diabetes Association
- Kaiser Permanente
- National Institute of Child Health and Human Development (R01‐HD34242, R01-HD-34243)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01-HD-34243, R01-HD-34242, R01HD034242, R01HD034243)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- gestational diabetes mellitus, hyperglycemia in pregnancy, IADPSG criteria, perinatal outcomes, maternal glycemia, diagnostic thresholds
- MeSH terms
- Female, Health Planning Guidelines, Humans, Hyperglycemia, International Cooperation, Pregnancy, Pregnancy Complications, Pregnancy in Diabetics, Societies, Medical, Diabetes, Gestational, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.